Stock MRUS MERUS N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Merus N.V.

Equities

MRUS

NL0011606264

Market Closed - Nasdaq
Other stock markets
 02:00:00 07/05/2024 am IST 		5-day change 1st Jan Change
47.34 USD -2.11% Intraday chart for Merus N.V. +4.94% +72.15%
19/04 Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says MT
28/03 Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC
GL
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
GL
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024
GL
Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024
AQ
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
GL
Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
AQ
Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression
GL
Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression
AQ
Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference
GL
Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference
AQ
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
GL
Merus to Participate in Upcoming Investor Conferences
GL
Merus to Participate in Upcoming Investor Conferences
AQ
Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 2023
AQ
Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 2023
GL
Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023
AQ
Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023
GL
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GL
Merus to Participate in Upcoming Investor Conferences
GL
Merus to Participate in Upcoming Investor Conferences
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRUS Stock
  4. News Merus N.V.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW